| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/(SICI)1098-2825(1998)12:5<293::AID-JCLA8>3.3.CO;2-B |
| P698 | PubMed publication ID | 9773961 |
| P2093 | author name string | Lewis S | |
| DeBari VA | |||
| Keil LB | |||
| Binder WL | |||
| P2860 | cites work | Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H) | Q24558202 |
| Site-directed mutagenesis of recombinant human beta 2-glycoprotein I identifies a cluster of lysine residues that are critical for phospholipid binding and anti-cardiolipin antibody activity | Q28293644 | ||
| Analytical and clinical relationships between human IgG autoantibodies to beta 2 glycoprotein I and anticardiolipin antibodies | Q41135009 | ||
| Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface | Q42084495 | ||
| The fifth domain of beta 2-glycoprotein I contains a phospholipid binding site (Cys281-Cys288) and a region recognized by anticardiolipin antibodies. | Q44828689 | ||
| Functional and binding studies of the roles of prothrombin and beta 2-glycoprotein I in the expression of lupus anticoagulant activity | Q46744324 | ||
| Phospholipid-independent binding of beta 2glycoprotein I by IgA from patients with antiphospholipid syndrome | Q47911070 | ||
| The association of antibodies to beta 2 glycoprotein I with the antiphospholipid syndrome: a meta-analysis. | Q53782876 | ||
| Association of anti-beta 2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus | Q68008000 | ||
| Measurement of anti-phospholipid antibodies by ELISA using beta 2-glycoprotein I as an antigen | Q68042865 | ||
| Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor | Q68090535 | ||
| The anticardiolipin syndrome | Q69573545 | ||
| Binding of beta 2 glycoprotein I to activated polystyrene and its recognition by human IgG autoantibodies | Q70929677 | ||
| Reference calibrators for IgG antibodies to beta2-glycoprotein I: preparation, properties and availability to investigators | Q71170745 | ||
| Autoimmune antiphospholipid antibodies are directed against a cryptic epitope expressed when beta 2-glycoprotein I is bound to a suitable surface | Q71691954 | ||
| Antibodies to beta 2 glycoprotein I: standardized immunoassay and a reference interval for healthy controls | Q71862678 | ||
| Antibodies to phospholipid-free beta 2-glycoprotein-I in patients with primary antiphospholipid syndrome | Q71965474 | ||
| Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies | Q71965477 | ||
| "Anticardiolipin" autoantibodies recognize beta 2-glycoprotein I in the absence of phospholipid. Importance of Ag density and bivalent binding | Q72393079 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 293-297 | |
| P577 | publication date | 1998-01-01 | |
| P1433 | published in | Journal of Clinical Laboratory Analysis | Q15754724 |
| P1476 | title | Standardized measurement of major immunoglobulin class (IgG, IgA, and IgM) antibodies to beta2glycoprotein I in patients with antiphospholipid syndrome | |
| P478 | volume | 12 |
Search more.